ALAMEDA, Calif., Feb. 14, 2017 — Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and year ended December 31, 2016, after market close on Tuesday, February 28, 2017 at 5:00 PM Eastern Time. A press release with fourth quarter and full year 2016 financial results will be issued after market close that day.
Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (877) 201-0168 for domestic callers or (647) 788-4901 for international callers (conference id: 58689898), or the webcast can be accessed on the “Events” section under the “Investors” tab of the Company’s website at: www.penumbrainc.com. The webcast will be available on the Company’s website for two weeks following the completion of the call.
Penumbra, Inc., headquartered in Alameda, California, is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The company has a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/penumbra-inc-schedules-fourth-quarter-and-full-year-2016-earnings-release-and-conference-call-for-february-28-2017-at-500-pm-eastern-time-300406344.html
SOURCE Penumbra, Inc.